3:53 PM
 | 
Sep 13, 2017
 |  BC Extra  |  Financial News

BioCryst, Portola price follow-ons

Portola Pharmaceuticals Inc. (NASDAQ:PTLA) and BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) priced follow-ons late Tuesday, raising over $420 million.

Portola raised $349 million through the sale of 6.4 million shares at $55 in a bumped-up follow-on underwritten by Morgan Stanley, Citigroup, Goldman Sachs, Cowen and William Blair. The price...

Read the full 221 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >